Boston Scientific's total assets for Q1 2025 were $40.14B, an increase of 1.89% from the previous quarter. BSX total liabilities were $17.69B for the fiscal quarter, a 1.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.